Premium
COVID‐19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients
Author(s) -
Wu Linda,
Girgis Christian M.,
Cheung Ngai Wah
Publication year - 2020
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.14288
Subject(s) - diabetes mellitus , medicine , insulin , intensive care unit , covid-19 , type 2 diabetes , critically ill , severity of illness , intensive care medicine , endocrinology , disease , infectious disease (medical specialty)
Objective In the light of increased adverse outcomes for people with diabetes affected by COVID‐19, we have described the clinical course of a cohort of critically ill patients with COVID‐19 and diabetes. Methods We retrospectively analysed characteristics, glucometrics and inflammatory markers of patients with diabetes mellitus admitted to intensive care unit (ICU) with COVID‐19. Results Eight patients with diabetes were admitted to ICU with COVID‐19. All had type 2 diabetes, with three being newly diagnosed that admission. Mean HbA1c was 9.2%. Glucometric analysis indicated that extremely high insulin doses were required during peak inflammatory response to maintain glycaemic control with a mean peak insulin requirement of 201 units per day (2.2 units/kg/day). Conclusions Critically unwell patients with diabetes mellitus and COVID‐19 had high insulin requirements and poorer time in target range at the time of peak inflammatory response, and this improved as their illness resolved.